61 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
be secured to fund those studies, and providing technology transfer, training and other support to be ready for clinical trial launch of RCS-01 and RCT
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
should partners be secured to fund those studies, and providing technology transfer, training and other support to be ready for clinical trial launch
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
of clinical studies in Japan for RCS-01 and RCT-01 should partners be secured to fund those studies, and (3) providing technology transfer, training
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
, training and other support to be ready for clinical trial launch of RCS-01 and RCT-01 in China with our partner, YOFOTO.
In combination with potential
20-F/A
bdouwl 7vc
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
pczwjc7y 36ukuogpx
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
z6qhgikj3t2 qt
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
ivbqy9ho
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
k91j45o kxjuwrl5
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.5
makfwflc3
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
5xvoyecplpyynfrtc9iv
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
z7458cxz54
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
2gj0kp 14lpc1lyec
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
s0bnruaov2x4 lptqn0h
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
4inv2bv3sdw4a
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
wgt1nu9xuscccwgxs0
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm